A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives among six key therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation.
Amgen started the operations in Taiwan since 2015, with the goal of to bringing more new treatments and clinical trials for patients in Taiwan. Over the years, Amgen Taiwan has devoted to delivering innovative health solutions to patients through innovative biologic therapies in bone health, cardiovascular disease, and oncology as well as value-based partnership with health care providers, governments, and local communities. In everything we do, we aim to fulfill our mission to serve patients.